Quest’s two AD-Detect blood-based tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer’s disease pathology in ...
Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...
Feb 1 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab beat fourth-quarter estimates and forecast 2024 sales above Wall Street expectation on Thursday, as it benefits from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback